NPCE as of Oct 31 · 18:36 ET
NPCENasdaqSurgical & Medical Instruments & Apparatus
NeuroPace Inc · Brief
Next report
3 days
Nov 3 · after closeest.Q3 FY26
Expected move
Inputs1 of 8≥ implied
- avg implied
- ±24.2%
- avg realized
- ±8.5%
Jan 8 '25±13.6%▼−0.58%×0.04
Mar 4 '25±17.1%▼−2.43%×0.14
May 13 '25±9.5%▲+20.46%×2.15
Aug 12 '25±17.0%▲+2.08%×0.12
Q3 FY25±55.7%▲+38.09%×0.68
Q1 FY26±32.3%▲+0.87%×0.03
May 12 '26±15.3%▲+0.06%×0.00
Q2 FY26±33.3%▼−3.26%×0.10
quarterimplied−60%0+60%realized×
Q2 FY26±33.3%▼−3.26%×0.10
May '26±15.3%▲+0.06%×0.00
Q1 FY26±32.3%▲+0.87%×0.03
Q3 FY25±55.7%▲+38.09%×0.68
Aug '25±17.0%▲+2.08%×0.12
May '25±9.5%▲+20.46%×2.15
2 older reports
Mar '25±17.1%▼−2.43%×0.14
Jan '25±13.6%▼−0.58%×0.04
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 3 report · est.Bull2 of 3
Bear2 of 4
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
NPCE report sessionSuppliers 1
× = co-movement · max 501dSource: SEC filings · market data
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.